Issac has over 14 years investment banking experience in M&A (sell and buy side) as well as corporate finance. Since joining PharmaVentures, Issac has worked with a broad range of clients in the healthcare and consumer sectors and recently advised on the sale of NanoSight Ltd. to Spectris plc.
Prior to joining PharmaVentures, Issac worked with the M&A and corporate finance teams at Citigroup and JP Morgan in New York and Bank of America and Standard Chartered Bank in London. He has executed advisory and financing projects exceeding $30bn in North America, Europe and Emerging Markets for clients including Sinochem Group, Ossur, AstraZeneca, AllianceBoots, Merck, Almirall, Tata Group and Telecom Italia.
Issac received a BA in Economics from Columbia College, a Masters in International Affairs from Columbia University and a MBA from Columbia Business School.